Multiple Sclerosis (MS)

  1. Mavenclad (cladribine)
    Mavenclad (cladribine)
    by Merck Serono Europe Limited
    for Multiple Sclerosis
    €2,612.80
  2. Ocrevus (ocrelizumab)
    Ocrevus (ocrelizumab)
    by Roche Registration Limited
    for Multiple Sclerosis
    €8,682.50
View as Grid List

2 Items

per page
Set Descending Direction

Just one thing before you continue

Our service contains information about acquiring treatments that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

No, take me out of here.
CONTINUE